RIGEL PHARMACEUTICALS INC Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Rigel Pharmaceuticals Inc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Rigel Pharmaceuticals Inc Operating Income (Loss) for the quarter ending September 30, 2024 was $14.1M.
  • Rigel Pharmaceuticals Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was $9.5M.
  • Rigel Pharmaceuticals Inc annual Operating Income (Loss) for 2023 was -$20.5M, a 63.1% increase from 2022.
  • Rigel Pharmaceuticals Inc annual Operating Income (Loss) for 2022 was -$55.6M, a 345% decline from 2021.
  • Rigel Pharmaceuticals Inc annual Operating Income (Loss) for 2021 was -$12.5M, a 56.9% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $9.5M $14.1M +$18.5M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$9.02M $447K +$5.71M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$14.7M -$6.97M +$5.76M +45.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$20.5M $1.97M -$113K -5.44% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 -$20.4M -$4.47M +$13.9M +75.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$34.3M -$5.27M +$7.7M +59.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$42M -$12.7M +$13.5M +51.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$55.6M $2.08M +$23.5M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 -$79M -$18.4M +$1.38M +6.99% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$80.4M -$13M +$83K +0.64% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 -$80.5M -$26.3M -$68M -163% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 -$12.5M -$21.4M -$2.59M -13.8% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-05
Q3 2021 -$9.91M -$19.8M -$6M -43.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$3.9M -$13M +$4.34M +25% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 -$8.25M $41.8M +$20.7M +98.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 -$29M -$18.8M -$1.49M -8.59% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-07
Q3 2020 -$27.5M -$13.8M -$1.74M -14.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$25.7M -$17.4M +$3.95M +18.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 -$29.7M $21M +$39.4M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$69.1M -$17.3M -$19.9M -785% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 -$49.2M -$12M +$12.3M +50.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$61.6M -$21.3M +$4.77M +18.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 -$66.3M -$18.4M +$6.36M +25.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 -$72.7M $2.53M +$28.7M Oct 1, 2018 Dec 31, 2018 10-K 2021-03-02
Q3 2018 -$101M -$24.4M -$6.52M -36.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 -$94.9M -$26.1M -$6.77M -35% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 -$88.1M -$24.7M -$8.53M -52.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$79.6M -$26.2M -$10.4M -66.1% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 -$69.2M -$17.9M +$4.88M +21.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 -$74.1M -$19.3M -$5.7M -41.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$68.4M -$16.2M +$1.37M +7.77% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-01
Q4 2016 -$69.7M -$15.8M -$3.04M -23.8% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 -$66.7M -$22.7M -$16M -235% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$50.7M -$13.6M +$326K +2.33% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-01
Q1 2016 -$51.1M -$17.6M +$674K +3.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-02
Q4 2015 -$51.7M -$12.7M +$9.62M +43% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-06
Q3 2015 -$61.4M -$6.78M +$14.3M +67.8% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-01
Q2 2015 -$75.6M -$14M +$11.5M +45.1% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-02
Q1 2015 -$87.1M -$18.2M +$4.14M +18.5% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-03
Q4 2014 -$91.2M -$22.4M -$5.42M -32% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-07
Q3 2014 -$85.8M -$21M +$2.89M +12.1% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-03
Q2 2014 -$88.7M -$25.5M -$2.57M -11.2% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-04
Q1 2014 -$86.1M -$22.4M +$3.33M +12.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 -$89.5M -$16.9M +$8.67M +33.9% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-08
Q3 2013 -$98.1M -$23.9M +$1.64M +6.41% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-04
Q2 2013 -$99.8M -$22.9M +$2M +8.03% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 -$102M -$25.7M -$2.4M -10.3% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 -$99.4M -$25.6M +$294K +1.14% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-03
Q3 2012 -$99.7M -$25.6M -$7.53M -41.7% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-05
Q2 2012 -$92.1M -$24.9M -$3.33M -15.4% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 -$88.8M -$23.3M -$2.45M -11.7% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-07
Q4 2011 -$86.4M -$25.9M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-04
Q3 2011 -$18M -$68.4M -136% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 -$21.6M -$48.5M -180% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 -$20.9M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-01
Q3 2010 $50.4M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-01
Q2 2010 $27M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.